Bayer Raises Profit Outlook on Strong Demand for Drugs

Bayer AG raised its annual profit outlook after stronger-than-expected performance at its pharmaceutical unit, driven by increased demand for newer drugs. The company's revised guidance reflects improved sales and margin expectations for the year, signaling confidence in its drug portfolio's growth trajectory despite broader market challenges.